American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
Pathomic analysis of 5-year surveillance biopsies as predictors of kidney allograft loss.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sarder Pinaki, Denic Aleksandar, Smith Byron H, Paul Anindya S, Gupta Akshita, Kasireddy Harishwar Reddy, Devarasetty Sumanth, Border Samuel P, Park Walter D, Stegall Mark D
Аннотация
This study aimed to assess whether various pathomic features in automatically segmented glomeruli and tubules were associated with death-censored graft loss in kidney transplant recipients. We studied 906 patients who were transplanted between 2000 and 2013, returned to Mayo Clinic for a 5-year surveillance biopsy, and had available subsequent follow-up. Banff scores were obtained from the pathology reports and clinical characteristics from the patients' charts. A multicompartment segmentation model segmented nonsclerotic glomeruli and tubules, and within these compartments, morphometric and textural (pathomic) features were computed. There were 70 death-censored graft losses that occurred during the 5 years of follow-up, and Cox models were used to assess the risk of death-censored graft failure with all Banff scores, with 2 composite pathomic features (glomeruli and tubules), and with Banff scores and pathomic features combined. The composite pathomic score model had similar performance to the Banff score model (c-statistics 0.845 vs 0.823, P = .47). A model combining the Banff scores and pathomic scores showed the best performance (c-statistic 0.897). We conclude that multicompartment segmentation models can identify pathomic features which can complement Banff scoring and are associated with future graft loss.